Addictions Therapeutics Market 2027 By Treatment Type, Drug Type, Treatment Center, Distribution Channel and Geography | The Insight Partners

Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Treatment Type (Opioid Addiction Treatment, Alcohol Addiction treatment, Nicotine Addiction treatment, Other substance addiction treatment); Drug Type (Nalaxone, Naltrexone, Bupropion, Disulfiram, Nicotine replacement products, Methadone, Varenicline); Treatment Center (Inpatient treatment center, Residential treatment Center, Outpatient Treatment Center); Distribution Channel (Hospital Pharmacies, Medical stores, Others) and Geography

Report Code: TIPRE00015265 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Addiction is referred to as a psychological and physical inability to stop consuming drugs, alcohol, Opioids and related category substances, even though those substances have various psychological and physical harms. An addiction develops dependency in a person to take that particular substance. Addiction can be life threatening if not stopped. So, to stop addictions there are several options available such as drug therapy, rehabilitation; which can stop addiction in better way.

MARKET DYNAMICS

The key market drivers for Addictions Therapeutics Market Includes, growing addiction cases worldwide along with unhealthy lifestyle among the people are the factors which would boost market during the forecast period. However, patent expiration of branded drugs and medications along with launch of genetic version of a drug are about to restrain market growth during the forecast period.

MARKET SCOPE

The "Addictions Therapeutics Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Addictions Therapeutics Market with detailed market segmentation by treatment type, drug type, treatment center and a distribution channel. The Addictions Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Addictions Therapeutics Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Addictions Therapeutics Market is segmented on the basis of treatment type, drug type, treatment center and a distribution channel. On the basis of treatment type it is divided as opioid addiction treatment, alcohol addiction treatment, nicotine addiction treatment and other substance addiction treatment. On basis of different drugs available such as naloxone, naltrexone, bupropion, disulfiram, nicotine replacement products, and methadone. On the basis of different treatment center such as inpatient treatment center, outpatient treatment center. And on the basis of different distribution channel such as, hospital pharmacy, medical store and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Addictions Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Addictions Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Addictions Therapeutics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Addictions Therapeutics Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Addictions Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Addictions Therapeutics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Addictions Therapeutics market in the global market. Below mentioned is the list of few companies engaged in the Addictions Therapeutics Market.

The report also includes the profiles of key players in Addictions Therapeutics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Cipla Ltd
  •   Allergan Plc
  •   Pfizer Inc
  •   Orexo AB
  •   GlaxoSmithKline Plc
  •   Purdue Pharma L.P
  •   Alvogen
  •   Bausch Health
  •   Currax Pharmaceuticals LLC
  •   Hikma Pharmaceuticals PLC

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmaceutical Grade Dextrose Glucose Market - By Type
1.3.2 Pharmaceutical Grade Dextrose Glucose Market - By Application
1.3.3 Pharmaceutical Grade Dextrose Glucose Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE - GLOBAL MARKET OVERVIEW
6.2. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. API GRADE
7.3.1. Overview
7.3.2. API Grade Market Forecast and Analysis
7.4. EXCIPIENT GRADE
7.4.1. Overview
7.4.2. Excipient Grade Market Forecast and Analysis
8. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PARENTERAL NUTRITION,DIALYSIS APPLICATIONS,INJECTABLE
8.3.1. Overview
8.3.2. Parenteral Nutrition,Dialysis Applications,Injectable Market Forecast and Analysis
9. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pharmaceutical Grade Dextrose Glucose Market Overview
9.1.2 North America Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis
9.1.3 North America Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Type
9.1.4 North America Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Application
9.1.5 North America Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pharmaceutical Grade Dextrose Glucose Market
9.1.5.1.1 United States Pharmaceutical Grade Dextrose Glucose Market by Type
9.1.5.1.2 United States Pharmaceutical Grade Dextrose Glucose Market by Application
9.1.5.2 Canada Pharmaceutical Grade Dextrose Glucose Market
9.1.5.2.1 Canada Pharmaceutical Grade Dextrose Glucose Market by Type
9.1.5.2.2 Canada Pharmaceutical Grade Dextrose Glucose Market by Application
9.1.5.3 Mexico Pharmaceutical Grade Dextrose Glucose Market
9.1.5.3.1 Mexico Pharmaceutical Grade Dextrose Glucose Market by Type
9.1.5.3.2 Mexico Pharmaceutical Grade Dextrose Glucose Market by Application
9.2. EUROPE
9.2.1 Europe Pharmaceutical Grade Dextrose Glucose Market Overview
9.2.2 Europe Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis
9.2.3 Europe Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Type
9.2.4 Europe Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Application
9.2.5 Europe Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pharmaceutical Grade Dextrose Glucose Market
9.2.5.1.1 Germany Pharmaceutical Grade Dextrose Glucose Market by Type
9.2.5.1.2 Germany Pharmaceutical Grade Dextrose Glucose Market by Application
9.2.5.2 France Pharmaceutical Grade Dextrose Glucose Market
9.2.5.2.1 France Pharmaceutical Grade Dextrose Glucose Market by Type
9.2.5.2.2 France Pharmaceutical Grade Dextrose Glucose Market by Application
9.2.5.3 Italy Pharmaceutical Grade Dextrose Glucose Market
9.2.5.3.1 Italy Pharmaceutical Grade Dextrose Glucose Market by Type
9.2.5.3.2 Italy Pharmaceutical Grade Dextrose Glucose Market by Application
9.2.5.4 Spain Pharmaceutical Grade Dextrose Glucose Market
9.2.5.4.1 Spain Pharmaceutical Grade Dextrose Glucose Market by Type
9.2.5.4.2 Spain Pharmaceutical Grade Dextrose Glucose Market by Application
9.2.5.5 United Kingdom Pharmaceutical Grade Dextrose Glucose Market
9.2.5.5.1 United Kingdom Pharmaceutical Grade Dextrose Glucose Market by Type
9.2.5.5.2 United Kingdom Pharmaceutical Grade Dextrose Glucose Market by Application
9.2.5.6 Rest of Europe Pharmaceutical Grade Dextrose Glucose Market
9.2.5.6.1 Rest of Europe Pharmaceutical Grade Dextrose Glucose Market by Type
9.2.5.6.2 Rest of Europe Pharmaceutical Grade Dextrose Glucose Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pharmaceutical Grade Dextrose Glucose Market Overview
9.3.2 Asia-Pacific Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis
9.3.3 Asia-Pacific Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pharmaceutical Grade Dextrose Glucose Market
9.3.5.1.1 Australia Pharmaceutical Grade Dextrose Glucose Market by Type
9.3.5.1.2 Australia Pharmaceutical Grade Dextrose Glucose Market by Application
9.3.5.2 China Pharmaceutical Grade Dextrose Glucose Market
9.3.5.2.1 China Pharmaceutical Grade Dextrose Glucose Market by Type
9.3.5.2.2 China Pharmaceutical Grade Dextrose Glucose Market by Application
9.3.5.3 India Pharmaceutical Grade Dextrose Glucose Market
9.3.5.3.1 India Pharmaceutical Grade Dextrose Glucose Market by Type
9.3.5.3.2 India Pharmaceutical Grade Dextrose Glucose Market by Application
9.3.5.4 Japan Pharmaceutical Grade Dextrose Glucose Market
9.3.5.4.1 Japan Pharmaceutical Grade Dextrose Glucose Market by Type
9.3.5.4.2 Japan Pharmaceutical Grade Dextrose Glucose Market by Application
9.3.5.5 South Korea Pharmaceutical Grade Dextrose Glucose Market
9.3.5.5.1 South Korea Pharmaceutical Grade Dextrose Glucose Market by Type
9.3.5.5.2 South Korea Pharmaceutical Grade Dextrose Glucose Market by Application
9.3.5.6 Rest of Asia-Pacific Pharmaceutical Grade Dextrose Glucose Market
9.3.5.6.1 Rest of Asia-Pacific Pharmaceutical Grade Dextrose Glucose Market by Type
9.3.5.6.2 Rest of Asia-Pacific Pharmaceutical Grade Dextrose Glucose Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pharmaceutical Grade Dextrose Glucose Market Overview
9.4.2 Middle East and Africa Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis
9.4.3 Middle East and Africa Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pharmaceutical Grade Dextrose Glucose Market
9.4.5.1.1 South Africa Pharmaceutical Grade Dextrose Glucose Market by Type
9.4.5.1.2 South Africa Pharmaceutical Grade Dextrose Glucose Market by Application
9.4.5.2 Saudi Arabia Pharmaceutical Grade Dextrose Glucose Market
9.4.5.2.1 Saudi Arabia Pharmaceutical Grade Dextrose Glucose Market by Type
9.4.5.2.2 Saudi Arabia Pharmaceutical Grade Dextrose Glucose Market by Application
9.4.5.3 U.A.E Pharmaceutical Grade Dextrose Glucose Market
9.4.5.3.1 U.A.E Pharmaceutical Grade Dextrose Glucose Market by Type
9.4.5.3.2 U.A.E Pharmaceutical Grade Dextrose Glucose Market by Application
9.4.5.4 Rest of Middle East and Africa Pharmaceutical Grade Dextrose Glucose Market
9.4.5.4.1 Rest of Middle East and Africa Pharmaceutical Grade Dextrose Glucose Market by Type
9.4.5.4.2 Rest of Middle East and Africa Pharmaceutical Grade Dextrose Glucose Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pharmaceutical Grade Dextrose Glucose Market Overview
9.5.2 South and Central America Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis
9.5.3 South and Central America Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Type
9.5.4 South and Central America Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Application
9.5.5 South and Central America Pharmaceutical Grade Dextrose Glucose Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pharmaceutical Grade Dextrose Glucose Market
9.5.5.1.1 Brazil Pharmaceutical Grade Dextrose Glucose Market by Type
9.5.5.1.2 Brazil Pharmaceutical Grade Dextrose Glucose Market by Application
9.5.5.2 Argentina Pharmaceutical Grade Dextrose Glucose Market
9.5.5.2.1 Argentina Pharmaceutical Grade Dextrose Glucose Market by Type
9.5.5.2.2 Argentina Pharmaceutical Grade Dextrose Glucose Market by Application
9.5.5.3 Rest of South and Central America Pharmaceutical Grade Dextrose Glucose Market
9.5.5.3.1 Rest of South and Central America Pharmaceutical Grade Dextrose Glucose Market by Type
9.5.5.3.2 Rest of South and Central America Pharmaceutical Grade Dextrose Glucose Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PHARMACEUTICAL GRADE DEXTROSE GLUCOSE MARKET, KEY COMPANY PROFILES
11.1. INGREDION INCORPORATED
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLOBAL SWEETENERS HOLDINGS LIMITED
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ARCHER DANIELS MIDLAND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CARGILL, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. TATE AND LYLE PLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ROUQUETTE FRERES S.A
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. AVEBE GROUP
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TEREOS SA
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. FEITIAN
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. LIHUA STARCH
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Cipla Ltd
2. Allergan Plc
3. Pfizer Inc
4. Orexo AB
5. GlaxoSmithKline Plc
6. Purdue Pharma L.p
7. Alvogen
8. Bausch Health
9. Currax Pharmaceuticals LLC
10. Hikma Pharmaceuticals PLC
TIPRE00015265
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking